OrbusNeich Medical Group Holdings Limited (6929.HK)
HKD 4.08
(-0.97%)
HKD 4.08
(-0.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 23.03 Million | 23.43 Million | 20.49 Million | 12.66 Million | 1.59 Million |
| Net Income | 49.62 Million | 21.79 Million | -1.31 Million | 7.25 Million | 6.95 Million |
| Depreciation & Amortization | 4.2 Million | 3.88 Million | 4.01 Million | 4.09 Million | 3.97 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 1.08 Million | 684 Thousand | 1.33 Million | - | - |
| Change in working capital | -17.94 Million | -4.74 Million | -3.54 Million | 2.81 Million | -8.73 Million |
| Other non-cash items | -10.53 Million | -920 Thousand | 5.59 Million | 1.39 Million | -604 Thousand |
| Investing Cash Flow | -52.31 Million | -169.31 Million | -5.21 Million | -11.24 Million | -3.05 Million |
| Investments in PPE | -7.47 Million | -3.33 Million | -2.14 Million | -3.75 Million | -2.73 Million |
| Acquisitions | -13.19 Million | - | - | -7.38 Million | - |
| Investment purchases | -55.32 Million | -162.83 Million | -407 Thousand | -390 Thousand | - |
| Sales/Maturities of investments | 20.66 Million | 40 Thousand | 144 Thousand | 157 Thousand | - |
| Other Investing Activities | -33.52 Million | -166.41 Million | -3.97 Million | -8.06 Million | -321 Thousand |
| Financing Cash Flow | 884 Thousand | 57.44 Million | 146.3 Million | -473 Thousand | 1.2 Million |
| Debt repayment | -4.23 Million | -1.42 Million | -39.66 Million | -6.23 Million | -36.75 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -815 Thousand | - | - | - | - |
| Common Stock Issuance | 184 Thousand | 61.63 Million | - | - | - |
| Other Financing Activities | 3.53 Million | 58.86 Million | -10.41 Million | -4 Million | -35.25 Million |
| Accounts receivables | -1.74 Million | -7.56 Million | -1.71 Million | 8.63 Million | -3.15 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -6.83 Million | -2.5 Million | -1.58 Million | -1.93 Million | -1.26 Million |
| Other working capital | -6.61 Million | 3.4 Million | -1.08 Million | -1.7 Million | -4.31 Million |
| Cash at beginning of period | 86.64 Million | 175.88 Million | 15.11 Million | 13.63 Million | 13.81 Million |
| Cash at end of period | 58.25 Million | 86.64 Million | 175.88 Million | 15.11 Million | 13.63 Million |
| Capital Expenditure | -7.47 Million | -3.33 Million | -2.14 Million | -3.75 Million | -2.73 Million |
| Effect of forex changes on cash | 5000.00 | -799 Thousand | -813 Thousand | 533 Thousand | 77 Thousand |
| Net cash flow / Change in cash | -28.39 Million | -89.24 Million | 160.77 Million | 1.48 Million | -181 Thousand |
| Free Cash Flow | 15.55 Million | 20.09 Million | 18.35 Million | 8.91 Million | -1.14 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.41 Million | 9.41 Million | 9.94 Million | 49.62 Million | 9.94 Million | 12.59 Million |
| Depreciation & Amortization | 1.3 Million | 1.3 Million | 1.08 Million | 4.2 Million | 872.5 Thousand | 1.01 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 10 Thousand | 10 Thousand | 446 Thousand | 1.08 Million | 446 Thousand | 94 Thousand |
| Change in working capital | - | - | -7.59 Million | -17.94 Million | -7.59 Million | - |
| Other non-cash items | -6.62 Million | -6.62 Million | 1.45 Million | -10.53 Million | 1.67 Million | -7.51 Million |
| Investing Cash Flow | -11 Million | -11 Million | -15.45 Million | -52.31 Million | -15.45 Million | -10.69 Million |
| Investments in PPE | -3.32 Million | -3.32 Million | -1.88 Million | -7.47 Million | -1.88 Million | -917 Thousand |
| Acquisitions | - | - | -6.59 Million | -13.19 Million | -6.59 Million | - |
| Investment purchases | - | - | - | -55.32 Million | - | - |
| Sales/Maturities of investments | - | - | - | 20.66 Million | - | - |
| Other Investing Activities | -7.68 Million | -7.68 Million | -6.97 Million | -33.52 Million | -6.97 Million | -9.78 Million |
| Financing Cash Flow | -6.2 Million | -6.2 Million | 1.29 Million | 884 Thousand | 1.29 Million | -851 Thousand |
| Debt repayment | - | - | - | -4.23 Million | - | - |
| Dividends payments | -5.3 Million | -5.3 Million | - | - | - | - |
| Common Stock Repurchased | -361 Thousand | -361 Thousand | -407.5 Thousand | -815 Thousand | -407.5 Thousand | - |
| Common Stock Issuance | - | - | - | 184 Thousand | - | - |
| Other Financing Activities | -535.5 Thousand | -535.5 Thousand | 1.7 Million | 3.53 Million | 1.7 Million | -851 Thousand |
| Accounts receivables | - | - | -871.5 Thousand | -1.74 Million | -871.5 Thousand | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -3.41 Million | -6.83 Million | -3.41 Million | - |
| Other working capital | - | - | -3.3 Million | -6.61 Million | -3.3 Million | - |
| Cash at beginning of period | - | - | - | 86.64 Million | - | - |
| Cash at end of period | -13.85 Million | -13.85 Million | -8.63 Million | 58.25 Million | -8.63 Million | -5.56 Million |
| Capital Expenditure | -3.32 Million | -3.32 Million | -1.88 Million | -7.47 Million | -1.88 Million | -917 Thousand |
| Effect of forex changes on cash | -750.5 Thousand | -750.5 Thousand | 198 Thousand | 5000.00 | 198 Thousand | -195.5 Thousand |
| Net cash flow / Change in cash | -13.85 Million | -13.85 Million | -8.63 Million | -28.39 Million | -8.63 Million | -5.56 Million |
| Free Cash Flow | 779 Thousand | 779 Thousand | 3.45 Million | 15.55 Million | 3.45 Million | 5.26 Million |
PBNNF
VRSSF
THR
BLLB
DNET
DWAHF